Abstract:Background: The mTOR gene regulates cell growth by controlling mRNA translation, ribosome biogenesis, autophagy, and metabolism. Abnormally increased expression of mTOR was associated with carcinogenesis, and its functional single nucleotide polymorphisms (SNPs) may regulate the expression of mTOR and thus contribute to cancer risk. Methodology/Principal Findings: In a hospital-based case-control study of 1004 prostate cancer (PCa) cases and 1051 cancer-free controls, we genotyped six potentially functional SNPs of mTOR (rs2536 T>C, rs1883965 G>A, rs1034528 G>C, rs17036508 T>C, rs3806317 A>G, and rs2295080 T>G) and assessed their associations with risk of PCa by using logistic regression analysis. Conclusions/Significances: In the single-locus analysis, we found a significantly increased risk of PCa associated with mTOR rs2536 CT/CC and rs1034528 CG/CC genotypes [adjusted OR = 1.42 (1.13-1.78), P = 0.003 and 1.29 (1.07-1.55), P = 0.007), respectively], compared with their common homozygous genotypes, whereas mTOR rs2295080 GT/GG genotypes were associated with a decreased risk of PCa [adjusted OR = 0.76 (0.64-0.92), P = 0.003], compared with wild-type TT genotypes. In the combined analysis of the six SNPs, we found that individuals carrying two or more adverse genotypes had an increased risk of PCa [adjusted OR = 1.24 (1.04-1.47), P = 0.016], compared with individuals carrying less than two adverse genotypes. In the multiple dimension reduction analysis, body mass index (BMI) was the best one-factor model with the highest CVC (100%) and the lowest prediction error (42.7%) among all seven factors. The model including an interaction among BMI, rs17036508, and rs2536 was the best three-factor model with the highest CVC (100%) and the lowest prediction error of 41.9%. These findings suggested that mTOR SNPs may contribute to the risk of PCa in Eastern Chinese men, but the effect was weak and needs further validation by larger population-based studies.

Genetic associations of visfatin polymorphisms with clinicopathologic characteristics of prostate cancer in Taiwanese males

Genetic Variant in Visfatin Gene Promoter is Associated with Decreased Risk of Coronary Artery Disease in a Chinese Population

A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease

Association Between Polymorphism in Vav3 Genes and Risk of Primary Prostatic Cancer in Chinese Han Population

The Association of Rs710886 in Lncrna PCAT1 with Bladder Cancer Risk in a Chinese Population.

Genetic Polymorphisms In Igf-I And Igfbp-3 Are Associated With Prostate Cancer In The Chinese Population

Genetic Variants in Insulin-Like Growth Factor Binding Protein-3 Are Associated with Prostate Cancer Susceptibility in Eastern Chinese Han Men

Mechanistic insights into the link between visfatin gene C-1535T polymorphism and coronary artery disease: an in vitro study

Functional Polymorphisms in Cell Death Pathway Genes FAS and FAS Ligand and Risk of Prostate Cancer in a Chinese Population.

The Visfatin Gene is Associated with Glucose and Lipid Metabolism in a Chinese Population.

Genetic polymorphisms in HIF 1 A are associated with prostate cancer risk in a Chinese population

Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study

Susceptibility loci associations with prostate cancer risk in northern Chinese men

Polymorphisms in the Mtor Gene and Risk of Sporadic Prostate Cancer in an Eastern Chinese Population

Polymorphisms at Long Non-Coding RNAs and Prostate Cancer Risk in an Eastern Chinese Population

Psca Polymorphisms and Gastric Cancer Susceptibility in an Eastern Chinese Population

Genetic Variations of the ADIPOQgene and Risk of Prostate Cancer in Chinese Han Men.

Genetic Variations In A Pten/Akt/Mtor Axis And Prostate Cancer Risk In A Chinese Population

Study on TFF1 and PALB2 Gene Variants Associated with Gastric Carcinoma Risk in the Chinese Han Population.

[Association of Polymorphisms in Testosterone 5-Alpha-reductase II Genotype and Prognosis Factors of Prostate Cancer].

Genetic variants in RTEL1 influencing telomere length are associated with prostate cancer risk.